Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. 1994

J Wang, and S J Smerdon, and J Jäger, and L A Kohlstaedt, and P A Rice, and J M Friedman, and T A Steitz
Department of Molecular Biophysics and Biochemistry, Howard Hughes Medical Institute, Yale University New Haven, CT 06520-8114.

The reverse transcriptase from human immunodeficiency virus type 1 is a heterodimer consisting of one 66-kDa and one 51-kDa subunit. The p66 subunit contains both a polymerase and an RNase H domain; proteolytic cleavage of p66 removes the RNase H domain to yield the p51 subunit. Although the polymerase domain of p66 folds into an open, extended structure containing a large active-site cleft, that of p51 is closed and compact. The connection subdomain, which lies between the polymerase and RNase H active sites in p66, plays a central role in the formation of the reverse transcriptase heterodimer. Extensive and very different intra- and intersubunit contacts are made by the connection subdomains of each of the subunits. Together, contacts between the two connection domains constitute approximately one-third of the total contacts between subunits of the heterodimer. Conversion of an open p66 polymerase domain structure to a closed p51-like structure results in a reduction in solvent-accessible surface area by 1600 A2 and the burying of an extensive hydrophobic surface. Thus, the monomeric forms of both p66 and p51 are proposed to have the same closed structure as seen in the p51 subunit of the heterodimer. The free energy required to convert p66 from a closed p51-like structure to the observed open p66 polymerase domain structure is generated by the burying of a large, predominantly hydrophobic surface area upon formation of the heterodimer. It is likely that the only kind of dimer that can form is an asymmetric one like that seen in the heterodimer structure, since one dimer interaction surface exists only in p51 and the other only in p66. We suggest that both p51 and p66 form asymmetric homodimers that are assembled from one subunit that has assumed the open conformation and one that has the closed structure.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012194 RNA-Directed DNA Polymerase An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49. DNA Polymerase, RNA-Directed,RNA-Dependent DNA Polymerase,Reverse Transcriptase,RNA Transcriptase,Revertase,DNA Polymerase, RNA Directed,DNA Polymerase, RNA-Dependent,RNA Dependent DNA Polymerase,RNA Directed DNA Polymerase
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D017510 Protein Folding Processes involved in the formation of TERTIARY PROTEIN STRUCTURE. Protein Folding, Globular,Folding, Globular Protein,Folding, Protein,Foldings, Globular Protein,Foldings, Protein,Globular Protein Folding,Globular Protein Foldings,Protein Foldings,Protein Foldings, Globular
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

J Wang, and S J Smerdon, and J Jäger, and L A Kohlstaedt, and P A Rice, and J M Friedman, and T A Steitz
September 1994, Protein science : a publication of the Protein Society,
J Wang, and S J Smerdon, and J Jäger, and L A Kohlstaedt, and P A Rice, and J M Friedman, and T A Steitz
August 2005, Journal of virology,
J Wang, and S J Smerdon, and J Jäger, and L A Kohlstaedt, and P A Rice, and J M Friedman, and T A Steitz
February 1996, Biological chemistry Hoppe-Seyler,
J Wang, and S J Smerdon, and J Jäger, and L A Kohlstaedt, and P A Rice, and J M Friedman, and T A Steitz
May 1992, Journal of virology,
J Wang, and S J Smerdon, and J Jäger, and L A Kohlstaedt, and P A Rice, and J M Friedman, and T A Steitz
February 1996, Biochemistry,
J Wang, and S J Smerdon, and J Jäger, and L A Kohlstaedt, and P A Rice, and J M Friedman, and T A Steitz
January 1994, The Journal of biological chemistry,
J Wang, and S J Smerdon, and J Jäger, and L A Kohlstaedt, and P A Rice, and J M Friedman, and T A Steitz
March 2006, The Journal of biological chemistry,
J Wang, and S J Smerdon, and J Jäger, and L A Kohlstaedt, and P A Rice, and J M Friedman, and T A Steitz
January 2004, Current topics in medicinal chemistry,
J Wang, and S J Smerdon, and J Jäger, and L A Kohlstaedt, and P A Rice, and J M Friedman, and T A Steitz
July 1991, Proceedings of the National Academy of Sciences of the United States of America,
J Wang, and S J Smerdon, and J Jäger, and L A Kohlstaedt, and P A Rice, and J M Friedman, and T A Steitz
April 1994, FEBS letters,
Copied contents to your clipboard!